2A95 Axelrod, Rita - Thomas Jefferson University - Thomas Jefferson University
Dr. Axelrod

Rita Axelrod, MD

Contact Dr. Axelrod

925 Chestnut Street
Suite 320A
Philadelphia, PA 19107

(215) 955-8874

Most Recent Peer-reviewed Publications

  1. Randomized phase III trial of concurrent accelerated radiation plus cisplatin with or without cetuximab for stage III to IV head and neck carcinoma: RTOG 0522
  2. Modeling the overall survival of patients with advanced-stage non-small cell lung cancer using data of routine laboratory tests
  3. E5501: Phase II study of topotecan sequenced with etoposide/cisplatin, and irinotecan/cisplatin sequenced with etoposide for extensive-stage small-cell lung cancer
  4. A Pilot Study of Hypofractionated Stereotactic Radiation Therapy and Sunitinib in Previously Irradiated Patients With Recurrent High-Grade Glioma
  5. Identification of a KRAS mutation in a patient with non-small cell lung cancer treated with chemoradiotherapy and panitumumab
  6. Sarcoidosis mimicking metastatic bone disease in head and neck cancer
  7. The addition of amifostine to carboplatin and paclitaxel based chemoradiation in locally advanced non-small cell lung cancer: Long-term follow-up of Radiation Therapy Oncology Group (RTOG) randomized trial 9801
  8. An economic model to value companion diagnostics in non-small-cell lung cancer
  9. Treatment-related acute esophagitis for patients with locoregionally advanced non-small cell lung cancer treated with involved-field radiotherapy and concurrent chemotherapy
  10. Uncommon Tumors of the Oral Cavity and Adjacent Structures
  11. Value of fluoro-2-deoxy-D-glucose-positron emission tomography for detecting metastatic lesions in head and neck cancer
  12. Phase I trial using the proteasome inhibitor bortezomib and concurrent chemoradiotherapy for head-and-neck malignancies
  13. Endovascular management of carotid blowout
  14. A phase 1b trial of the combination of the antiangiogenic agent sunitinib and radiation therapy for patients with primary and metastatic central nervous system malignancies
  15. A phase 2 trial of bortezomib followed by the addition of doxorubicin at progression in patients with recurrent or metastatic adenoid cystic carcinoma of the head and neck: A trial of the Eastern Cooperative Oncology Group (E1303)
  16. Phase i study of 'dose-dense' pemetrexed plus carboplatin/radiotherapy for locally advanced non-small cell lung carcinoma
  17. Phase I Trial Using Patupilone (Epothilone B) and Concurrent Radiotherapy for Central Nervous System Malignancies
  18. Human papillomavirus and survival of patients with oropharyngeal cancer
  19. Introduction: Women and Lung Cancer
  20. Docetaxel and irinotecan in recurrent or metastatic head and neck cancer: A phase 2 trial of the eastern cooperative oncology group
0